Atezolizumab with or without radiotherapy for advanced squamous cell carcinoma of the penis
Atezolizumab with or without radiotherapy for advanced squamous cell carcinoma of the penis
Challenges and perspective of cancer patients during the COVID-19 pandemic and the Lebanese financial crisis
Tailoring radiation therapy in the 21st century
Preventive oncology nutrition for healthy carriers and BRCA1/2 + breast cancer patients
Brentuximab vedotin and CHP benefit over CHOP for CD30-positive PTCL
International Society of Paediatric Surgical Oncology (IPSO) surgical practice guidelines
PET scanning in patients with classical Hodgkin lymphoma outside of Europe and North America
Update: Cabozantinib plus nivolumab demonstrates continued survival benefit in aRCC
KEYNOTE 564 update: Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for patients with renal cell carcinoma
ASCO GU 2022: What to watch out for in renal
Maintenance PARP inhibition following chemotherapy for metastatic urothelial carcinoma
First randomized trial on adjuvant mitotane in adrenocortical carcinoma patients: The Adjuvo study.